Pro Dex Inc
PDEXNasdaqCIK 788920HealthcareFiscal year ends Jun 30
Reports and events: 341 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3016:07 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001079973-26-001415 |
| 2026-10-2916:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-26-001411 |
| 2026-10-2916:01 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001079973-26-001410 |
| 2026-10-0616:01 ET | DEF 14A | Proxy statementPeriod 2026-11-19 | 0001079973-26-001325 |
| 2026-09-1816:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001079973-26-001261 |
| 2026-09-0316:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-26-001216 |
| 2026-09-0316:09 ET | 10-K | Annual reportPeriod 2026-06-30 | 0001079973-26-001215 |
| 2026-08-2816:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001079973-26-001196 |
| 2026-06-2617:59 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000897069-26-001456 |
| 2026-06-1717:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-26-000854 |
| 2026-04-3016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-26-000581 |
| 2026-04-3016:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001079973-26-000580 |
| 2026-03-2716:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001079973-26-000372 |
| 2026-02-1216:01 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-26-000201 |
| 2026-01-2916:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-26-000141 |
| 2026-01-2916:00 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001079973-26-000140 |
| 2025-12-1916:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001079973-25-001880 |
| 2025-11-2116:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001553350-25-000115 |
| 2025-10-3016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-25-001656 |
| 2025-10-3016:02 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001079973-25-001655 |
| 2025-10-0716:05 ET | DEF 14A | Proxy statementPeriod 2025-11-20 | 0001079973-25-001567 |
| 2025-09-0416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-25-001427 |
| 2025-09-0416:00 ET | 10-K | Annual reportPeriod 2025-06-30 | 0001079973-25-001426 |
| 2025-08-1516:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001079973-25-001335 |
| 2025-06-0516:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001079973-25-000990 |
| 2025-05-0116:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-25-000730 |
| 2025-05-0116:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001079973-25-000729 |
| 2025-04-1116:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001079973-25-000614 |
| 2025-04-0417:29 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000897069-25-000771 |
| 2025-03-2719:03 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001058465-25-000006 |
| 2025-01-3016:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-25-000165 |
| 2025-01-3016:00 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001079973-25-000164 |
| 2025-01-2916:39 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001058465-25-000004 |
| 2024-12-2716:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001079973-24-001778 |
| 2024-11-2516:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001079973-24-001630 |
| 2024-11-2213:59 ET | 8-K | 5.07 Shareholder vote results | 0001079973-24-001607 |
| 2024-10-3116:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-24-001463 |
| 2024-10-3116:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001079973-24-001462 |
| 2024-10-2516:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001079973-24-001443 |
| 2024-10-0816:00 ET | DEF 14A | Proxy statementPeriod 2024-11-21 | 0001079973-24-001369 |
| 2024-09-0516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001553350-24-000080 |
| 2024-09-0516:00 ET | 10-K | Annual reportPeriod 2024-06-30 | 0001553350-24-000079 |
| 2024-08-0916:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001079973-24-001188 |
| 2024-08-0516:49 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001079973-24-001167 |
| 2024-05-0216:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-24-000640 |
| 2024-05-0216:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001079973-24-000639 |
| 2024-02-0816:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-24-000182 |
| 2024-02-0816:01 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001079973-24-000181 |
| 2024-01-0416:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001079973-24-000018 |
| 2024-01-0316:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001079973-24-000007 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:16 ET. Listed shows no prices and gives no investment advice.